Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review

[1]  H. Weiner,et al.  An argument for broad use of high efficacy treatments in early multiple sclerosis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[2]  M. Sormani,et al.  Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) , 2019, Bone Marrow Transplantation.

[3]  Jeffrey A. Cohen,et al.  Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  B. Sharrack,et al.  Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial , 2019, JAMA.

[5]  J. Lechner-Scott,et al.  Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis , 2019, JAMA.

[6]  Jaume Sastre-Garriga,et al.  Treatment of multiple sclerosis — success from bench to bedside , 2018, Nature Reviews Neurology.

[7]  L. Wilkins.  Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis , 2017, Neurology.

[8]  M. Sormani,et al.  Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis , 2017, Nature Reviews Neurology.

[9]  E. Havrdová,et al.  “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis , 2017, Multiple sclerosis.

[10]  D. Douek,et al.  Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients , 2005, The Journal of experimental medicine.

[11]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. , 1991, Brain : a journal of neurology.

[12]  E. Leray,et al.  Epidemiology of multiple sclerosis. , 2016, Revue neurologique.